Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | ELV | COR | NTRA | VTRS |
| Company | Charles River Laboratories Intl | Elevance Health Inc | Cencora Inc | Natera Inc | Viatris Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 185.84 | 397.17 | 242.16 | 153.42 | 12.92 |
| High | 188.38 | 400.00 | 243.93 | 162.20 | 13.07 |
| Low | 183.91 | 391.83 | 240.50 | 152.00 | 12.79 |
| Last | 186.10 | 394.20 | 240.98 | 162.10 | 13.05 |
| Change | -1.40 | -6.50 | -1.89 | +8.68 | +0.05 |
| % Change | -0.75% | -1.62% | -0.78% | +5.66% | +0.38% |
| Volume | 714,400 | 2,000,400 | 820,200 | 2,111,300 | 7,385,600 |
| 20-Day Average Volume | 888,955 | 1,987,725 | 1,281,425 | 1,438,365 | 7,533,905 |
| Previous Close | 187.50 | 400.70 | 242.87 | 153.42 | 13.00 |
| Industry | Medical Services | Medical Services | Medical Services | Medical Services | Medical Services |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 193.77 | 414.33 | 239.31 | 132.74 | 12.22 |
| 20-Day Raw Stochastic | 17.97% | 5.64% | 55.19% | 88.74% | 81.52% |
| 20-Day Relative Strength | 44.22% | 28.13% | 54.78% | 68.67% | 63.29% |
| Weighted Alpha | -14.22 | -26.71 | +16.81 | +180.09 | +36.70 |
| Today's Opinion | 96% Sell | 100% Sell | 72% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 96% Sell | 100% Sell | 72% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 72% Sell | 56% Buy | 64% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.82% since 11/12/24 | -4.53% since 11/12/24 | -3.14% since 11/12/24 | +19.97% since 11/12/24 | +0.93% since 11/12/24 |
| Low | 183.35 on 11/15/24 | 391.83 on 11/19/24 | 237.48 on 11/15/24 | 143.20 on 11/15/24 | 12.53 on 11/15/24 |
| High | 217.75 on 11/13/24 | 415.74 on 11/13/24 | 251.10 on 11/13/24 | 167.79 on 11/13/24 | 13.09 on 11/14/24 |
| 1-Month | |||||
| %Chg | -5.90% since 10/18/24 | -8.49% since 10/18/24 | +1.50% since 10/18/24 | +32.43% since 10/18/24 | +10.97% since 10/18/24 |
| Low | 176.48 on 10/31/24 | 391.83 on 11/19/24 | 227.95 on 10/31/24 | 117.27 on 10/28/24 | 11.33 on 11/05/24 |
| High | 230.02 on 11/06/24 | 435.61 on 10/21/24 | 251.56 on 11/12/24 | 167.79 on 11/13/24 | 13.44 on 11/07/24 |
| 3-Month | |||||
| %Chg | -8.78% since 08/19/24 | -27.46% since 08/19/24 | +0.89% since 08/19/24 | +30.96% since 08/19/24 | +10.31% since 08/19/24 |
| Low | 176.48 on 10/31/24 | 391.83 on 11/19/24 | 218.65 on 10/07/24 | 110.57 on 09/06/24 | 10.85 on 09/10/24 |
| High | 230.02 on 11/06/24 | 567.26 on 09/03/24 | 251.56 on 11/12/24 | 167.79 on 11/13/24 | 13.44 on 11/07/24 |
| 6-Month | |||||
| %Chg | -16.02% since 05/17/24 | -28.03% since 05/17/24 | +8.49% since 05/17/24 | +52.26% since 05/17/24 | +18.85% since 05/17/24 |
| Low | 176.48 on 10/31/24 | 391.83 on 11/19/24 | 214.77 on 05/29/24 | 92.14 on 08/05/24 | 9.93 on 06/18/24 |
| High | 254.15 on 08/01/24 | 567.26 on 09/03/24 | 251.56 on 11/12/24 | 167.79 on 11/13/24 | 13.44 on 11/07/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,588,000 | 92,931,552 | 47,856,804 | 20,254,662 | 15,516,709 |
| Shares Outstanding, K | 51,136 | 231,923 | 197,047 | 132,021 | 1,193,593 |
| Annual Sales | 4,129,410,000 | 171,340,000,000 | 293,958,590,000 | 1,082,570,000 | 15,426,900,000 |
| Annual Net Income | 474,620,000 | 5,987,000,000 | 1,509,120,000 | -434,800,000 | 54,700,000 |
| Last Quarter Sales | 1,009,760,000 | 45,106,000,000 | 79,050,110,000 | 439,760,000 | 3,751,200,000 |
| Last Quarter Net Income | 69,280,000 | 1,016,000,000 | 3,380,000 | -31,590,000 | 94,800,000 |
| 60-Month Beta | 1.38 | 0.85 | 0.44 | 1.53 | 0.93 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.59 on 11/06/24 | 8.37 on 10/17/24 | 3.34 on 11/06/24 | -0.26 on 11/12/24 | 0.75 on 11/07/24 |
| Latest Earnings Date | 11/06/24 | 10/17/24 | 11/06/24 | 11/12/24 | 11/07/24 |
| Most Recent Dividend | N/A | 1.630 on 09/10/24 | 0.550 on 11/15/24 | N/A | 0.120 on 08/23/24 |
| Next Ex-Dividends Date | N/A | 12/05/24 | 11/15/24 | N/A | 11/22/24 |
| Ratios | |||||
| Price/Earnings ttm | 18.55 | 11.53 | 17.46 | 0.00 | 4.72 |